A Study to Identify Predictors of Response to Duloxetine in Breast Cancer Patients With Chronic Pain
Phase of Trial: Phase II
Latest Information Update: 11 Jul 2019
Price : $35 *
At a glance
- Drugs Duloxetine (Primary)
- Indications Pain
- Focus Therapeutic Use
- 15 Jan 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Mar 2022.
- 31 Aug 2017 Status changed from active, no longer recruiting to recruiting.
- 03 Feb 2017 Planned End Date changed from 1 Jul 2017 to 1 Mar 2023.